Dynamic Studies Demo All Studies With Links.csv Study PI Collection Subjects with DNA Links to Data* Study 01 - Genetics of Opioid Dependence Joel Gelernter Opioid-Cocaine Dependence 4,848 NIDA Repository Study 02 - Mapping Susceptibility Genes for Nicotine Dependence Ming D. Li Nicotine Dependence 1,962 NIDA Repository Study 03 - Molecular Genetics of Heroin Dependence in China Ming Tsuang Opioid Dependence 1,232 NIDA Repository, dbGaP Study 05 - Addictions, Genotypes, Polymorphisms, and Function Mary Jeanne Kreek Opioid Dependence 1,751 NIDA Repository, dbGaP Study 06 - The Genetics of Vulnerability to Nicotine Pamela Madden Nicotine Dependence 2,663 NIDA Repository, dbGaP Study 07 - An Introduction to the Family Study of Cocaine Laura Bierut Cocaine Dependence 1,049 NIDA Repository Study 08 - Mu Opioid Receptor Gene in Heroin Addicts Lei Yu Opioid Dependence Combined with Study 5 Study 09 - Differentiation of Phenotypes for Smoking: Administrative Supplement to Join NIDA Genetics Consortium Ovide Pomerleau Nicotine Dependence 1,540 NIDA Repository Study 10 - Pharmacokinetics of Nicotine in Twins Gary Swan Nicotine Dependence 62 NIDA Repository Study 11 - Adolescent Drug Dependence John Hewitt Polysubstance Dependence 1,589 NIDA Repository Study 12 - Substance Abuse and the Dopamine System Genes Michael M. Yanyukov Polysubstance Dependence 470 NIDA Repository Study 13 - Genetics of Cocaine Induced Psychosis Joseph F. Cubells Cocaine Dependence 230 NIDA Repository Study 14 - Genome-Wide Analysis for Addiction Susceptibility Genes Herb Lachman Opioid Dependence 693 NIDA Repository, dbGaP Study 15 - Nicotine Dependence Laura Bierut Nicotine Dependence 3,424 NIDA Repository Study 16 - Nicotine Dependence Mark Leppert Nicotine Dependence 917 NIDA Repository Study 17 - Opioid Dependence Wade Berrettini Opioid Dependence 200 NIDA Repository Study 18 - Opioid Dependence: Candidate Genes and G x E Effects Elliot Nelson Opioid Dependence 1,895 NIDA Repository Study 19 - Epidemiological Study of Substance Abuse Rob Philibert Polysubstance Dependence 520 NIDA Repository Study 20 - Innovative Approaches for Cocaine Pharmacotherapy Henry Kranzler Opioid-Cocaine Dependence 219 NIDA Repository Study 21 - Twin Family Study of Vulnerability to Substance Abuse William Iacono Polysubstance Dependence Combined with Study 25 Study 22 - Exploring the Genetic Basis for Drug Use Hallam Hurt Polysubstance Dependence Closed Study 23 - Substance Use Disorder Liability: Candidate Gene System Michael M. Vanyukov Polysubstance Dependence 886 NIDA Repository Study 24 - START Pharmacogenetics: Exploratory Genetic Studies in Starting Treatment with Agonist Replacement Therapies (START) Wade Berrettini Opioid Dependence 785 NIDA Repository, dbGaP Study 25 - The Genes, Environment, and Development Initiative (GEDI) William Iacono Other dbGaP Study 26 - The Genes, Environment, and Development Initiative (GEDI) E. Jane Costello Other dbGaP Study 27 - The Genetic Study of Nicotine Dependence in African Americans (AAND) Laura Bierut Nicotine Dependence 1,792 NIDA Repository Study 28 - Center on Antisocial Drug Dependence: the Genetics of HIV Risk Behavior John Hewitt Other NIDA Repository* Study 29 - Genetics Protocol of the Cocaine Use Reduction with Buprenorphine (CURB) Study; CTN-0048 David A. Nielsen Cocaine Dependence 278 Clinical Trials Network Study 30 - Phase 2: Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial of Nepicastat for Cocaine Dependence Thomas R. Kosten Cocaine Dependence NIDA Repository* Study 31 - Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT); CTN-0051 John Rotrosen Smokescreen 615 dbGaP, Clinical Trials Network Study 32 - Achieving Cannabis Cessation-Evaluation of N-Acetylcysteine (ACCENT); CTN-0053 Kevin Gray Other 204 Clinical Trials Network Study 33 - Genome-wide Association Study of HIV-1 Host Genetics Among Injection Drug Users Eric Johnson Other dbGaP Study 34 - Attention Deficit-Hyperactivity Disorder (ADHD) Robert K. Moyzis Other NIDA Repository* Study 35 - Genetically Informative Smoking Cessation Trial Li-Shiun Chen Nicotine Dependence 873 NIDA Repository Study 36 - Genetic Dissection in Pedigrees of Substance Use and Mood Disorders Comorbidity Nelson B. Freimer Other NIDA Repository* Study 37 - Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder; CTN-0068 Madhukar Trivedi Other 243 Clinical Trials Network Study 38 - Adolescent Brain Cognitive Development (ABCD) Study Other 10,217 NIMH Data Archive Study 39 - Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone: Improving the Real-World Effectiveness of Injection Naltrexone for Opioid Use Disorder (SWIFT); CTN-0097 Adam Bisaga Opioid Dependence 246 Clinical Trials Network* Study 40 - Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTREY); CTN-0098 Gavin Bart Opioid Dependence 15 Clinical Trials Network* Study 41 - Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy; CTN-0100 Edward Nunes Opioid Dependence 472 Clinical Trials Network* Study 42 - Genetics Analysis of Substance Use Disorder Using the Indiana Biobank Data Dongbing Lai Other dbGaP* Study 43 - Pediatric Imaging, Neurocognition, and Genetics (PING) Terry Jernigan Other TBA Study 44 - Randomized, Placebo-Controlled Trial of Injectable Naltrexone and Monthly Injectable Buprenorphine for Cocaine Use Disorder (CURB-2); CTN-0109 Madhukar Trivedi Cocaine Dependence Clinical Trials Network* Study 45 - Randomized, Double-Blind, Placebo-Controlled Trial of Monthly Injectable Buprenorphine for Methamphetamine Use Disorder (MURB); CTN-0110 Steve Shoptaw Polysubstance Dependence Clinical Trials Network* Study 46 - Advancing Genomics Research of Substance Use Disorders in Latin American Populations Janitza Montalvo-Ortiz & Humberto Nicolini Polysubstance Dependence TBA Study 51 - Genotyping on Smokescreen Microarray Chip Jasmin Vassileva & Alexandre Todorov Smokescreen dbGaP studies: phs001647, phs001804 Study 52 - Genetic Contribution to the Abuse Liability of Oxycodone Jermaine Jones Smokescreen dbGaP Study 53 - The Women’s Interagency HIV Study (WIHS) Brad Aouizerat Smokescreen dbGaP Study 54 - Genotyping on Smokescreen Microarray Chip Deborah Mash Smokescreen dbGaP Study 55 - ALIVE Cohort Smokescreen GWAS Brion Maher Smokescreen dbGaP Study 56 - Assess the Cardiovascular, Cognitive, and Subjective Effects of Atomoxetine in Combination with IV Methamphetamine Edythe London Smokescreen dbGaP Study 57 - Neural Systems, Inhibitory Control, and Methamphetamine Dependence Edythe London Smokescreen dbGaP Study 58 - Early Methamphetamine Abstinence fMRI and Brain Function Edythe London Smokescreen dbGaP Study 59 - Smokescreen; Opioid/Cocaine Use; Antisocial Drug Dependence Robin Corley Smokescreen dbGaP Study 60 - Gene-Environment Interactions in COCCaINE Use Disorder: Collaborative Case-Control Initiative in Cocaine Addiction Rodrigo Grassi-Oliveira Smokescreen dbGaP Study 61 - Smokescreen; NJD/NID Cohort Stanley Weiss Smokescreen dbGaP Study 62 - Prevention of Viral Hepatitis and HIV in Drug Users - A Hepatitis B Model for HIV and an HB Vaccine Model (DASH) Lu-Yu Hwang Smokescreen dbGaP Study 63 - Smokescreen; InC3 Cohort Substance Abusers Kimberly Page Smokescreen dbGaP Study 64 - Smokescreen; Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS) Inga Peter Smokescreen dbGaP Study 65 - Spit for Science Danielle Dick Smokescreen dbGaP Study PI Collection Subjects with DNA Links to Data*
